Navigation Links
They were right after all
Date:1/31/2008

This release is also available in German.

Drugs derived from cinchona bark, known as cinchona alkaloids, have been used in healing from ancient times. The most prominent representative of this group is quinine, a bitter substance contained in beverages such as tonic water and used in modern medicine to combat malaria. As early as 1945, Robert Burns Woodward and William von Eggers Doering (Harvard University) described how to synthesize quinine in the laboratory. The last step of this formal total synthesis, a three-step reaction procedure previously described by Paul Rabe and Karl Kindler in 1918, has continued to be the subject of much controversy to this day. Aaron C. Smith and Robert M. Williams at Colorado State University (USA) have now successfully reproduced the RabeKindler protocol. As described in an Angewandte Chemie article dedicated to Doering on his 90th birthday, they repeated the entire procedure without employing any modern methods.

Had they done it or not? That has been the question for decades. Woodward and Doering published the synthesis of d-quinotoxine in 1944. Based on the conversion of d-quinotoxine into quinine described by Rabe and Kindler in 1918, they claimed to have derived the total synthesis of quinine, though they had not actually completed this last step themselves before publishing. Their formal total synthesis was strongly challenged and was even dismissed as a myth by Gilbert Stork (Columbia University) in 2001.

Quinine and the cinchona bark alkaloids play an important role in modern medicine. It is thus amazing that no attempts to reproduce the RabeKindler conversion of quinotoxine into quinine have been published, marvels Williams. Smith and Williams reviewed the old publications, researched further references, and set themselves the task of repeating the procedure outlined by Rabe and Kindlerand with techniques available at the time. Initially, the yield of quinine they obtained was far too low. The key turned out to be the aluminum powder used as a reducing agent in the last step. It must not be too fresh, instead it must be exposed to air for a while first to produce a small amount of aluminum oxide. This results in yields of quinine in agreement with those in the old publications.

Analytically pure quinine can be isolated from this reaction by the selective crystallization of the corresponding tartrate salt, just as described by Rabe in 1939, says Williams. We have thus corroborated Rabe and Kindlers 1918 publication. Woodward and Doering could theoretically also have followed this procedure in 1944.


'/>"/>

Contact: Robert M. Williams
rmw@chem.colostate.edu
970-491-6747
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Bright Options for Medicare Beneficiaries in Louisiana
2. A Bright Future for Medicare Beneficiaries in Maine
3. KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM)
4. Phony Physicians Committee Suing Restaurants is Animal-Rights Trojan Horse, says CCF
5. Wachovia Foundation Announces $1 Million Each for Atlanta BeltLine Partnership, Center for Civil and Human Rights
6. Brighton Hospital Announces Creation of Brighton National Addiction Foundation
7. Exercise Your Right to Vote and Continue to Make a Difference by Giving Blood in 2008
8. AARP Calls New EEOC Policy A Civil Rights and Economic Fiasco
9. Make 2008 the Year to Find an Insurance Agent Thats Right for You
10. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
11. AAPD to Present 2008 Henry B. Betts Award to International Human Rights Disability Advocate Eric Rosenthal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp ... in and around the greater Phoenix metropolitan region, is announcing a charity event ... mission of the Homeless Youth Connection is to promote community awareness of the ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication ... one of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department ... on both sides of the Atlantic with a mechanism to comply with EU data ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... treat wrinkles and deep lines by smoothing and tightening the skin of the ... out there to address facial aging with very little downtime, Silhouette Instalift is ...
(Date:12/7/2016)... , ... December 07, 2016 , ... It is vital ... is with useful, properly analyzed data. The team at Beckman Coulter has designed Kaluza, ... 'need for speed' and the need to operate in a GLP (Good Laboratory Practice) ...
(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles on his ... the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his family ... hospital’s 30th heart transplant recipient. , “He was playing at home, when we got ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Dec. 7, 2016 A new investigational drug originally ... clinical trials in search of the world,s first treatment to ... of research findings today in the journal Science ... be a watershed moment for millions of people living with ... of Van Andel Research Institute,s Center for ...
(Date:12/7/2016)... 2016 DelveInsight,s, "Janus Kinase 3 ... depth insights on the pipeline drugs and ... 3 (JAK3) Inhibitors. The DelveInsight,s Report covers ... development including Discovery, Pre-clinical, IND, Phase I, ... covers the product clinical trials information and ...
(Date:12/7/2016)... Dec. 7, 2016 Hoovers Research ... performed using the combinational analytical tools. The report ... varied research sources to present unique and reliable ... on the market during the next five years, ... which comprises of sub markets, regional and country ...
Breaking Medicine Technology: